A significant study published in the September 3, 2025, issue of Neurology®, the medical journal of the American Academy of Neurology, has revealed a concerning association between high consumption of certain low- and no-calorie artificial sweeteners and a faster decline in thinking and memory skills over time. The research, conducted on a large cohort of adults in Brazil, adds a crucial layer to the ongoing global debate surrounding the health impacts of sugar substitutes, particularly highlighting potential long-term risks to brain health. While the study established a compelling link, it emphasized that it did not prove causation, calling for further investigation into the precise mechanisms at play.
The findings emerged from an extensive analysis involving 12,772 adults across Brazil, with participants followed for an average of eight years. The study cohort, with an average age of 52 at the outset, provided a robust dataset to track dietary habits and cognitive changes over a considerable period. Researchers meticulously examined the intake of seven common low- and no-calorie sweeteners: aspartame, saccharin, acesulfame-K, erythritol, xylitol, sorbitol, and tagatose. These compounds are ubiquitous in the modern diet, predominantly found in a vast array of ultra-processed foods such as flavored water, diet sodas, energy drinks, certain yogurts, and low-calorie desserts, in addition to being available as standalone tabletop sweeteners.
Detailed Findings on Cognitive Decline
Participants were initially categorized into three groups based on their total artificial sweetener consumption, derived from comprehensive dietary questionnaires completed at the study’s commencement. The lowest consumption group averaged 20 milligrams per day (mg/day), while the highest group consumed an average of 191 mg/day. To provide context, 191 mg/day of aspartame is roughly equivalent to the amount found in a single can of diet soda. Sorbitol registered the highest average individual consumption among the sweeteners, at 64 mg/day.
Cognitive assessments, including tests designed to measure memory, language, and various thinking skills, were administered at the beginning, midway point, and conclusion of the study. These tests evaluated critical areas such as verbal fluency, working memory, word recall, and processing speed. After rigorously adjusting for a range of confounding factors, including age, sex, pre-existing high blood pressure, and cardiovascular disease, the results painted a clear picture: individuals in the highest consumption group exhibited a significantly faster decline in overall thinking and memory skills. This decline was measured at an alarming 62% faster compared to those in the lowest consumption group, an effect researchers quantified as equivalent to approximately 1.6 years of accelerated cognitive aging. The middle consumption group also experienced a notable decline, registering 35% faster than the lowest group, translating to about 1.3 years of accelerated aging.
Age-Specific and Diabetes-Related Observations
One of the study’s particularly insightful findings pertained to age-specific differences. The research indicated that the link between high sweetener consumption and faster cognitive decline was predominantly observed in individuals under the age of 60. Within this younger demographic, those consuming the highest amounts of sweeteners showed more rapid declines in verbal fluency and overall cognition compared to their counterparts with the lowest intake. Interestingly, these links were not found in participants over the age of 60, suggesting potential age-dependent vulnerabilities or different metabolic responses to these compounds.
Furthermore, the study highlighted a stronger association between artificial sweetener use and accelerated cognitive decline among participants diagnosed with diabetes. This observation is particularly pertinent given that individuals with diabetes often rely on artificial sweeteners as a sugar substitute to manage blood glucose levels. Dr. Claudia Kimie Suemoto, MD, PhD, of the University of São Paulo in Brazil, a lead author of the study, remarked on this point: "While we found links to cognitive decline for middle-aged people both with and without diabetes, people with diabetes are more likely to use artificial sweeteners as sugar substitutes. This makes the findings particularly relevant for this population, who are already at a higher risk for certain health complications."
When the researchers disaggregated the data to examine individual sweeteners, they found that aspartame, saccharin, acesulfame-K, erythritol, sorbitol, and xylitol were all associated with a faster decline in overall cognition, with a specific emphasis on memory impairments. Notably, no link was identified between the consumption of tagatose and cognitive decline, suggesting potential differences in the metabolic or neurological impacts of various artificial sweeteners.
Background and Context: The Rise of Sugar Substitutes
The impetus for studies like this stems from decades of public health efforts to combat rising rates of obesity, type 2 diabetes, and cardiovascular disease, all strongly linked to excessive sugar intake. Beginning in the mid-20th century, and accelerating dramatically in recent decades, artificial sweeteners were introduced to offer the taste of sweetness without the caloric load of sugar. They were quickly embraced by the food industry and consumers alike, marketed as "diet" or "sugar-free" alternatives, seemingly offering a guilt-free indulgence. This led to a pervasive presence of these compounds in countless food and beverage products, fundamentally altering the modern dietary landscape.
From the initial approval of saccharin in the early 20th century, followed by aspartame in the 1980s, and a host of others since, these substances have been subject to intense scrutiny, regulatory review, and public debate. Early concerns often centered around potential links to cancer, which largely proved unsubstantiated in large-scale human studies for many approved sweeteners. However, more recent research has shifted focus to other potential health implications, including effects on the gut microbiome, metabolic regulation, and now, increasingly, neurological health. The Brazilian study represents a significant contribution to this evolving understanding, moving beyond caloric considerations to investigate broader systemic impacts.
Implications and Future Directions
Dr. Suemoto underscored the prevailing perception that these substitutes are unequivocally healthy alternatives to sugar. "Low- and no-calorie sweeteners are often seen as a healthy alternative to sugar; however, our findings suggest certain sweeteners may have negative effects on brain health over time," she stated. This statement challenges a long-held dietary assumption and necessitates a re-evaluation of public health messaging surrounding these products.
The study, while robust, acknowledges certain limitations. It did not encompass every artificial sweetener currently available on the market, and the reliance on self-reported dietary information always carries a potential for recall inaccuracies. Crucially, the observational nature of the study means it can only demonstrate an association, not a direct cause-and-effect relationship. Establishing causation would require more complex, long-term interventional studies where participants are randomized to consume specific sweeteners versus placebos, a research design that presents significant ethical and practical challenges over extended periods.
Despite these limitations, the findings carry substantial implications for public health, dietary guidelines, and the food industry. Public health bodies may need to consider refining their advice on sweetener consumption, especially for vulnerable populations such as middle-aged adults and those with diabetes. For consumers, the study serves as a critical reminder to exercise caution and consider whole, unprocessed foods as the cornerstone of a healthy diet.
The food industry, heavily reliant on these sweeteners for its "diet" and "light" product lines, may face increased pressure to explore alternatives or even reduce overall sweetness in products. Dr. Suemoto’s call for more research to investigate "if other refined sugar alternatives, such as applesauce, honey, maple syrup or coconut sugar, may be effective alternatives" points towards a potential shift in focus for product development, away from synthetic compounds towards more naturally derived options, though these often come with their own caloric and glycemic considerations.
Future research will likely delve deeper into the biological mechanisms by which artificial sweeteners might influence brain health. Hypotheses could include their impact on the gut-brain axis, given the known influence of gut microbiota on neurological function, or direct effects on vascular health and cerebral blood flow, or even neuroinflammatory pathways. Understanding these mechanisms will be crucial for validating the observed associations and developing targeted interventions.
This study was supported by significant funding from Brazilian governmental bodies, including the Brazilian Ministry of Health, the Ministry of Science, Technology, and Innovation, and the National Council for Scientific and Technological Development, underscoring the national importance placed on understanding dietary impacts on public health in Brazil. As the global consumption of artificial sweeteners continues to rise, driven by increasing health consciousness and the pursuit of low-calorie options, this research from the University of São Paulo provides a compelling new dimension to the discussion, urging both caution and further scientific exploration into the long-term cognitive consequences of our modern dietary choices.
